FTC’s Crackdown on COVID Claims: Insights on Novel Regulation from the Integrative Canaries in the Coal Mine

COVID Claims

News feeds for the natural products and integrative health practitioner fields have in recent weeks included a drumbeat of alerts on actions of the Food and Trade Commission (FTC) on what the agency considers inappropriate COVID claims. A major natural health organization blasted the FTC’s efforts as practitioner gagging andRead …

Read moreFTC’s Crackdown on COVID Claims: Insights on Novel Regulation from the Integrative Canaries in the Coal Mine

Put the Script Pad Down: FDA’s New Drug Approvals Pose Significant Risks

chronic inflammation

For every 100 new drugs introduced in the market, there have been 34 withdrawals or new black box warnings in the past 25 years. Since 1992, FDA sped up the pace and approval process for pharmaceutical companies willing to pay a fee. Approval time was cut in half, but with it came a significant number of safety withdrawals and warnings. This study, released today in Health Affairs, shows the expeditious process has placed millions of Americans at risk, essentially making them unwitting members of safety trials after the drug was approved.